
Ram R. Shukla
Supervisory Patent Examiner (ID: 2673, Phone: (469)295-9050 , Office: P/1600 )
| Most Active Art Unit | |
| Art Unit(s) | |
| Total Applications | |
| Issued Applications | |
| Pending Applications | |
| Abandoned Applications |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
| 09/284753 | FRINGE PROTEINS AND NOTCH SIGNALLING | Jun 10, 1999 | Abandoned |
| 09/308696 | NOVEL RECEPTOR | Jun 10, 1999 | Abandoned |
| 09/328925 | Nucleotide sequences for gene regulation and methods of use thereof | Jun 8, 1999 | Issued |
| 09/328710 | METHOD FOR IDENTIFYING COMPOUNDS WHICH AFFECT SYNAPTOGENESIS | Jun 8, 1999 | Abandoned |
| 09/327045 | TARGETED ANGIOGENESIS | Jun 6, 1999 | Abandoned |
| 09/321987 | Agent and method for modulation of cell migration | May 27, 1999 | Issued |
| 09/318888 | MODELS OF PRION DISEASE | May 25, 1999 | Abandoned |
| 09/306998 | MMSC2--an MMAC1 interacting protein | May 6, 1999 | Issued |
| 09/307265 | Ras suppressor SUR-5 | May 5, 1999 | Issued |
| 09/302952 | Combination viral-based and gene-based therapy of tumors | Apr 29, 1999 | Issued |
| 09/302094 | METHOD FOR INDUCING GROWTH AND ENHANCING SURVIVAL OF NERVOUS TISSUE | Apr 28, 1999 | Abandoned |
| 09/291541 | Methods and vector constructs for making non-human animals which ubiquitously express a heterologous gene | Apr 13, 1999 | Issued |
| 09/290333 | Nucleic acids encoding a lymphocyte surface receptor that binds CAML | Apr 11, 1999 | Issued |
| 09/281674 | Methods for regulating gene expression | Mar 29, 1999 | Issued |
| 09/276820 | Compositions and methods for non-targeted activation of endogenous genes | Mar 25, 1999 | Issued |
| 09/272068 | Dual-tagged proteins and their uses | Mar 17, 1999 | Issued |
| 09/314855 | Uses for non-autologous mesenchymal stem cells | Mar 11, 1999 | Issued |
| 09/266261 | NOVEL COMPOUNDS | Mar 10, 1999 | Abandoned |
| 09/262721 | CHIMERIC TRANSCRIPTION FACTORS | Mar 3, 1999 | Abandoned |
| 09/242977 | METHOD FOR RECOMBINANT ADENO-ASSOCIATED VIRUS-DIRECTED GENE THERAPY | Feb 25, 1999 | Abandoned |